MEDIFAST, INC.
Add to a list
To use this feature you must be a member
Log inSign up
MED
US58470H1014
Food Processing| Market Closed - Nyse Other stock markets | 5-day change | 1st Jan Change | ||
| 21.46 USD | -1.78% |  | -16.63% | -68.07% |
| 06-05 | DA Davidson Downgrades Medifast to Underperform From Neutral With $17.50 Price Target | MT |
| 04-30 | Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance | MT |
This article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Latest news about Medifast, Inc.
| DA Davidson Downgrades Medifast to Underperform From Neutral With $17.50 Price Target | MT | |
| Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance | MT | |
| Wall Street Poised for Cautious Day Ahead of Key Numbers, Earnings, Fed Report | MT | |
| Top Premarket Decliners | MT | |
| North American Morning Briefing : More Earnings Roll In; Fed Decision Looms | DJ | |
| Transcript : Medifast, Inc., Q1 2024 Earnings Call, Apr 29, 2024 | ||
| Earnings Flash (MED) MEDIFAST Reports Q1 EPS $0.66 | MT | |
| Earnings Flash (MED) MEDIFAST Reports Q1 Revenue $174.7M, vs. Street Est of $173.5M | MT | |
| Medifast, Inc. Provides Earnings Guidance for the Second Quarter of 2024 | CI | |
| Medifast, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI | |
| Medifast, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI | |
| Transcript : Medifast, Inc., Q4 2023 Earnings Call, Feb 20, 2024 | ||
| Earnings Flash (MED) MEDIFAST Posts Q4 EPS $1.09, vs. Street Est of $0.96 | MT | |
| Earnings Flash (MED) MEDIFAST Reports Q4 Revenue $191M, vs. Street Est of $184.2M | MT | |
| Medifast Provides Earnings Guidance for the First Quarter of 2024 | CI | |
| Medifast, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI | |
| Health Care Climbs After Fed Policy Move -- Health Care Roundup | DJ | |
| Medifast, LifeMD Collaborate to Offer Weight Management Solution; Medifast Scraps Quarterly Dividend | MT | |
| Transcript : LifeMD, Inc., Medifast, Inc. - Special Call | ||
| Medifast's Board of Directors Elect to Discontinue the Company's Quarterly Cash Dividend | CI | |
| Medifast Initiates Business Transformation by Entering the Medically Supported Weight Loss Market through Collaboration with LifeMD, Inc | CI | |
| Tranche Update on Medifast, Inc.'s Equity Buyback Plan announced on December 9, 2013. | CI | |
| Medifast, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI | |
| Transcript : Medifast, Inc., Q3 2023 Earnings Call, Nov 06, 2023 | ||
| Earnings Flash (MED) MEDIFAST Posts Q3 Revenue $235.9M, vs. Street Est of $232.1M | MT |
Chart Medifast, Inc.
More charts
Company Profile
Medifast, Inc. is a health and wellness company. The Company provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support. Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders. Its operations are conducted through its subsidiaries.
Sector
Food Processing
Calendar
19/06/2024 - Annual General Meeting
Related indices
Russell 2000
More about the company
Income Statement Evolution
More financial data
Ratings for Medifast, Inc.
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Analysts' Consensus
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
21.46USD
Average target price
21.25USD
Spread / Average Target
-0.98%
Consensus
EPS Revisions
Estimates Revisions
Quarterly earnings - Rate of surprise
Company calendar
| 1st Jan change | Capi. | |
|---|---|---|
MEDIFAST, INC. | -68.07% | 230M |
ZHEJIANG NHU COMPANY LTD. | +10.73% | 7.96B |
BELLRING BRANDS, INC. | +5.95% | 7.66B |
CSPC INNOVATION PHARMACEUTICAL CO., LTD. | -0.58% | 5.88B |
THE SIMPLY GOOD FOODS COMPANY | -6.11% | 3.72B |
BYHEALTH CO., LTD | -13.21% | 3.47B |
XIAMEN KINGDOMWAY GROUP COMPANY | -15.49% | 1.16B |
HERBALIFE LTD. | -26.41% | 1.12B |
SIRIO PHARMA CO., LTD. | +9.98% | 948M |
USANA HEALTH SCIENCES, INC. | -11.42% | 905M |
- Stock Market
- Equities
- MED Stock
- News Medifast, Inc.
- DA Davidson Downgrades Medifast to Underperform From Neutral With $17.50 Price Target
